Ortiz, O, Daca-Alvarez, M, Rivero-Sanchez, L, Gimeno-Garcia, AZ, Carrillo-Palau, M, Alvarez, V, Ledo-Rodriguez, A, Ricciardiello, L, Pierantoni, C, Hüneburg, R, Nattermann, J, Bisschops, R, Tejpar, S, Huerta, A, Pons, FR, Alvarez-Urturi, C, López-Vicente, J, Repici, A, Hassan, C, Cid, L, Cavestro, GM, Romero-Mascarell, C, Gordillo, J, Puig, I, Herraiz, M, Betes, M, Herrero, J, Jover, R, Balaguer, F, Pellisé, M. An artificial intelligence-assisted system versus white light endoscopy alone for adenoma detection in individuals with Lynch syndrome (TIMELY): an international, multicentre, randomised controlled trial. Lancet Gastroenterology & Hepatology. 2024; 9(9)DOI:10.1016/S2468-1253(24)00187-0. PMID:39033774. IF:38.600(Q1/1D).

Brujats, A, Huerta, A, Osuna-Gómez, R, Guinart-Cuadra, A, Ferrero-Gregori, A, Pujol, C, Soriano, G, Poca, M, Fajardo, J, Escorsell, A, Gallego, A, Vidal, S, Villanueva, C, Alvarado-Tapias, E. Immune Response and Risk of Decompensation following SARS-CoV-2 Infection in Outpatients with Advanced Chronic Liver Disease. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(15)DOI:10.3390/ijms25158302. PMID:39125872. IF:4.900(Q1/3D).

Ruiz-Cobo, JC, Llaneras, J, Forns, X, Moya, AG, Amiel, IC, Arencibia, A, Diago, M, Garcia-Samaniego, J, Castellote, J, Llerena, S, Rodriguez-Seguel, E, Mateos, B, Rodriguez, M, Zabal, JMR, Fernandez, I, Calleja, JL, Morillas, RM, Montoliu, S, Andrade, RJ, Aranda, EB, Hernandez-Guerra, M, Mate, CJ, Gonzalez-Santiago, JM, de Cuenca, B, Bernal-Monterde, V, Delgado, M, Turnes, J, Lens, S, Buti, M. Real-life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2024; 60(2)DOI:10.1111/apt.18020. PMID:38695095. IF:6.700(Q1/1D).

Ferreiro-Iglesias, R, Silva, SP, Marín, S, Casanova, MJ, Mañosa, M, González-Muñoza, C, de Francisco, R, Caballol, B, Arias, L, Piqueras, M, Zabana, Y, Rivero, M, Calvet, X, Mesonero, F, Trastoy, PV, Nistal, RB, Perosanz, RG, Vega, P, Gonzalez-Vivo, M, Iborra, M, Bermejo, F, Madero, L, Rodríguez-Lago, I, Gonzalez, MR, Vera, I, Díaz, AP, Vela, M, Medina, LT, Van Domselaar, M, Gomollón, F, Iglesias, E, Gisbert, JP, Calafat, M, Giordano, A, Pérez-Martínez, I, Ricart, E, Sicilia, B, Mena, R, Esteve, M, Rivas, C, Brunet-Mas, E, Fernández, C, Turrión, MAD, Jiménez, BV, Calvo, MQ, Expósito, CR, Márquez-Mosquera, L, Nos, P, Granja, A, Gutiérrez, A, Cabriada, JL, Cruz, DH, Calvo, M, Pérez, JP, Díaz, YR, Casal, DB, Menacho, M, Leal, C, Lucendo, AJ, Royo, V, Olivares, S, Herrero, BA, Carrillo-Palau, M, Alvarez, PG, Marcos, NM, Martínez-Pérez, TD, Villafranca, MCM, Almela, P, Argüelles-Arias, F, Legido, J, Coronel, AMF, Nieto, L, Domènech, E, Acosta, MBD. Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2024; 60(5)DOI:10.1111/apt.18133. PMID:38943230. IF:6.700(Q1/1D).